Viewing Study NCT00384956


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-05-04 @ 8:29 AM
Study NCT ID: NCT00384956
Status: COMPLETED
Last Update Posted: 2016-12-12
First Post: 2006-10-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes
Sponsor: Washington University School of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDS either de novo or secondary, fitting any of the … View